Indivior Pharmaceuti...
NasdaqGS:INDV
£ 29,95
£-0,31 (-1,02%)
29,95 £
£-0,31 (-1,02%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

£1,86
Earnings Per Share
£7,36
Revenue Per Share
84,02%
Gross Margin %
£3,75 B
Market Cap
£0,22 B
Long-Term Debt
Earnings Per Share
£1,86
Revenue Per Share
£7,36
Gross Margin %
84,02%
Market Cap
£3,75 B
Long-Term Debt
£0,22 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
EPS Earnings Per Share £1,86 £1,33 £1,23 £0,96 £0,66 £0,29 £0,87 £1,41 £1,37 £1,38 £1,15 £1,86
Earnings Earnings £232,63M £165,80M £167,71M £131,02M £92,72M £42,55M £127,16M £205,42M £197,68M £198,89M £165,28M £267,32M
RPS Revenue Per Share £0,00 £7,36 £7,61 £6,29 £5,48 £4,16 £3,23 £4,06 £5,41 £5,60 £5,95 £4,78 £4,98
Revenue Revenue £0,00M £920,58M £948,94M £858,09M £747,78M £584,17M £473,89M £592,71M £788,53M £808,66M £856,90M £687,59M £715,44M
OCF Operating Cash Flow £0,00M £-20,06M £16,77M £-247,30M £-3,32M £260,70M £-141,36M £114,01M £237,74M £218,26M £329,64M £216,99M £282,33M
FCF Free Cash Flow £0,00M £-69,10M £-6,39M £-324,24M £-188,40M £250,36M £-144,29M £112,50M £234,60M £186,44M £301,29M £198,68M £280,40M
OM Operating Margin 0,00% 31,23% 24,92% 22,60% 23,86% 23,64% 13,60% 25,73% 33,03% 17,66% 36,58% 37,18% 50,40%
GM % Gross Margin % 0,00% 84,02% 84,01% 84,08% 83,24% 83,94% 85,78% 82,17% 87,26% 90,48% 90,93% 90,43% 91,48%
FCFS Free Cash Flow Per Share £0,00 £-0,56 £0,03 £-2,02 £-0,05 £1,72 £-0,98 £0,77 £1,61 £1,29 £2,09 £1,36 £1,85
LT Debt Long-Term Debt N/A £215,47M £251,61M £186,06M £196,70M £176,51M £168,46M £175,93M £185,95M £352,91M £351,51M £387,20M £461,35M
Sha. Stocks 125M 125,07M 124,66M 136,35M 136,48M 140,49M 146,73M 146,16M 145,69M 144,29M 144,12M 143,72M 143,72M
×